×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Tarsons Products Limited | 758.6 | 35.7 | 712.79 | 0.67 | 1,706 | 62.0 |
| BLISS GVS PHARMA LTD. | 1739.57 | 210.53 | 1633.64 | 1.98 | 1635 | 15.4 |
| SYNCOM FORMULATIONS (INDIA) LT | 1225.67 | 157.29 | 1165.47 | 0.21 | 1628 | 28.3 |
Tarsons Products Limited, with Security Code 543399, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82.1 | 62.6 | 66.3 | 61.8 | 86.6 | 64.8 | 80.1 | 76.2 | 93.0 | 71.3 |
| Expenses | 42.8 | 41.3 | 40.9 | 38.9 | 52.8 | 47.8 | 56.6 | 48.2 | 56.0 | 49.1 |
| Operating Profit | 39.3 | 21.3 | 25.4 | 22.9 | 33.9 | 17.0 | 23.5 | 27.9 | 37.0 | 22.2 |
| OPM % | 47.84% | 34.04% | 38.27% | 37.05% | 39.1% | 26.25% | 29.32% | 36.65% | 39.81% | 31.19% |
| Other Income | 2.2 | 2.3 | 2.6 | 3.4 | 5.9 | 4.9 | 10.7 | 2.1 | 6.4 | 4.6 |
| Interest | 2.1 | 2.4 | 0.9 | 2.5 | 4.1 | 4.2 | 4.7 | 4.1 | 4.5 | 4.3 |
| Depreciation | 8.3 | 8.3 | 9.7 | 10.1 | 10.2 | 9.0 | 12.0 | 15.6 | 17.5 | 17.8 |
| Profit before tax | 31.1 | 12.9 | 17.3 | 13.7 | 25.5 | 8.7 | 17.5 | 10.3 | 21.4 | 4.8 |
| Tax % | -26.6% | -25.3% | -26.1% | -26.5% | -26.4% | -25.9% | -26.2% | -26.1% | -26.2% | 25.3% |
| Net Profit | 22.8 | 9.6 | 12.8 | 10.1 | 18.8 | 6.5 | 12.9 | 7.6 | 15.7 | 3.6 |
| EPS in Rs | 4.29 | 1.8 | 2.41 | 1.89 | 3.53 | 1.21 | 2.43 | 1.43 | 0 | 0.67 |
| Metrics | Dec 2021 | Mar 2022 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 70.7 | 84.9 | 61.8 | 105.7 | 84.8 | 99.2 | 95.7 | 112.7 |
| Expenses | 37.5 | 40.6 | 38.9 | 75.5 | 66.0 | 73.9 | 66.0 | 75.6 |
| Operating Profit | 33.1 | 44.3 | 22.9 | 30.2 | 18.8 | 25.3 | 29.6 | 37.1 |
| OPM % | 46.89% | 52.2% | 37.04% | 28.61% | 22.12% | 25.5% | 30.97% | 32.94% |
| Other Income | 2.5 | 2.6 | 3.2 | 3.4 | 2.9 | 8.4 | 0.8 | 3.8 |
| Interest | 1.4 | 0.5 | 2.5 | 4.3 | 4.3 | 4.8 | 5.0 | 5.2 |
| Depreciation | 5.3 | 7.2 | 10.1 | 12.3 | 11.0 | 14.0 | 17.4 | 20.0 |
| Profit before tax | 28.9 | 39.2 | 13.6 | 17.0 | 6.3 | 14.9 | 8.0 | 15.7 |
| Tax % | -25.7% | -24.9% | -26.7% | -39.5% | 36.4% | 30.8% | 34.7% | -34% |
| Net Profit | 21.5 | 29.5 | 9.9 | 10.3 | 4.0 | 10.3 | 5.3 | 10.2 |
| EPS in Rs | 4.14 | 5.69 | 1.87 | 1.94 | 0.75 | 1.93 | 0.99 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 7% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 6% |
| 3 Years: | -9% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -17% |
| 1 Year: | -12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 9% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -15% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -17% |
| 1 Year: | -12% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|